SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-21-080591
Filing Date
2021-03-15
Accepted
2021-03-15 08:27:59
Documents
3
Group Members
HORIZON THERAPEUTICS USA, INC.TEIRIPIC MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d14488dsctota.htm SC TO-T/A 44167
2 EX-99.(A)(5)(F) d14488dex99a5f.htm EX-99.(A)(5)(F) 38432
3 GRAPHIC g14488dsp001.jpg GRAPHIC 2018
  Complete submission text file 0001193125-21-080591.txt   87379
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filed by) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address 1 MEDIMMUNE WAY GAITHERSBURG MD 20878 240-558-0038
Viela Bio, Inc. (Subject) CIK: 0001734517 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-91167 | Film No.: 21739918
SIC: 2834 Pharmaceutical Preparations